Clinical Trial Update: Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS) [NA]

View source ↗

Summary

This completed clinical trial evaluated the effect of intrapulmonary recombinant human activated protein C on coagulation and inflammation following lipopolysac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Recombinant human activated protein C (activated protein C)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Pneumonia, Lipopolysaccharides | NA | Status: COMPLETED